Prof Ooi Eng Eong on Novavax’s application for approval to use its protein-based vaccine in S’pore

Novavax is seeking approval for use of its COVID-19 jab in Singapore. If interim permission is granted, it will be the first protein-based coronavirus shot available locally under the Special Access Route. The jab has shown promising results in overseas trials. Prof Ooi Eng Eong from the emerging infectious diseases programme at Duke-NUS Medical School shared his thoughts on protein-based vaccines and how likely they will hold up against coronavirus variants.

Subscribe to our channel here: https://cna.asia/youtubesub

Subscribe to our news service on Telegram: https://cna.asia/telegram

Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia

New Application Note – Berkeley Nucleonics Corporation / Arbitrary Waveform Generator for Mems Research

This application note describes how to use the Model 675 High Performance Arbitrary Waveform Generator to generate the signals for the test and design of Ultrasonic MEMS sensors.

(PRWeb November 16, 2021)

Read the full story at https://www.prweb.com/releases/new_application_note_berkeley_nucleonics_corporation_arbitrary_waveform_generator_for_mems_research/prweb18311340.htm

New nationwide eGIRO service will shorten application process from weeks to minutes

People in Singapore can soon have their GIRO applications with banks processed within minutes, instead of weeks. A new digital service will cut down on the paperwork. GIRO is a system that lets consumers make recurring bill payments from bank accounts. More than a million GIRO applications are made each year on average. In its initial phase, the service will be offered by eight major banks progressively and 13 billing organisations. The central bank said the move marks a significant step towards a more inclusive digital economy.

Subscribe to our channel here: https://cna.asia/youtubesub

Subscribe to our news service on Telegram: https://cna.asia/telegram

Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia